Newsletters
Turkish Parliament has passed new legislation introducing significant health sector reforms, including the controlled sale of medical cannabis products in pharmacies.
The new law, titled “Amendments to Certain Health-Related Laws and Decree Law No. 663,” allows for the regulated production and distribution of low-THC cannabis-based medicinal products. These products are distinct from recreational cannabis and do not induce psychoactive effects.
Under the legislation:
Only licensed pharmacies will be permitted to sell these products, and their use will remain restricted to prescribed medical treatments.
Medical cannabis is already in use across countries like Germany, Canada, Israel, Australia, and the Netherlands, mainly for patients suffering from chronic pain, cancer, or multiple sclerosis.
Taner Ercanli, a board member of the Turkish Pharmacists’ Association, emphasized that medical cannabis has analgesic and antidepressant effects, and is strictly different from recreational marijuana:
“We’re referring to pharmaceutical-grade products, not illicit street cannabis. These are approved and regulated by the Ministry of Health and have no place on the black market.”
2 min read
2 min read
